trial

The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis

NCTId NCT04916626

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

— · Active Not Recruiting

Enrollment 284 (estimated)

Sponsored by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital

Primary completion 2026-03

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Active Not Recruiting

Enrollment

284 (estimated)

Study type

Interventional

Allocation

Randomized

Model

Parallel

Masking

Double

Start

2021-05-06

Primary completion

2026-03

Eligibility

ALL · 12 Years · 17 Years

Interventions & indications

Drugs

OPUS YOUNG

Indications

Schizotypal Personality Disorder Psychoses, Substance-Induced Schizotypal Disorder Schizoaffective Disorder Acute and Transient Psychotic Disorder, Unspecified Schizophrenia, Paranoid Psychotic Disorders Schizophrenia Non-Organic Psychosis Schizophrenia Substance Induced Psychoses Delusional Disorder

Investigators

Anne K Pagsberg, PhDPrincipal Investigator

Sites

1 total

Hellerup, Denmark

Facts & assertions

4 sourced

Enrollment

284

Phase

Primary Completion Date

2026-03

Status

ACTIVE_NOT_RECRUITING

relationships

The graph out of here

drug

OPUS YOUNG

drug

lead_sponsor

Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital

company

indication

Schizotypal Personality Disorder

indication

Psychoses, Substance-Induced

indication

Schizotypal Disorder

indication

investigator

Anne K Pagsberg, PhD

person